LPL Financial’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$195M Buy
3,212,769
+359,262
+13% +$20.9M 0.05% 348
2025
Q4
$154M Buy
2,853,507
+134,497
+5% +$6.47M 0.04% 406
2025
Q3
$123M Buy
2,719,010
+199,985
+8% +$9.34M 0.04% 455
2025
Q2
$117M Sell
2,519,025
-749,529
-23% -$36.8M 0.04% 427
2025
Q1
$199M Sell
3,268,554
-122,853
-4% -$7.16M 0.08% 245
2024
Q4
$192M Buy
3,391,407
+344,201
+11% +$19.2M 0.08% 224
2024
Q3
$158M Buy
3,047,206
+80,435
+3% +$3.77M 0.07% 249
2024
Q2
$123M Buy
2,966,771
+529,123
+22% +$23.7M 0.06% 273
2024
Q1
$132M Buy
2,437,648
+533,070
+28% +$27.2M 0.07% 247
2023
Q4
$97.7M Sell
1,904,578
-121,474
-6% -$6.38M 0.06% 289
2023
Q3
$118M Buy
2,026,052
+72,947
+4% +$4.47M 0.08% 217
2023
Q2
$125M Buy
1,953,105
+131,293
+7% +$8.8M 0.09% 205
2023
Q1
$126M Buy
1,821,812
+224,031
+14% +$15.8M 0.1% 191
2022
Q4
$115M Sell
1,597,781
-64,039
-4% -$4.83M 0.1% 195
2022
Q3
$118M Sell
1,661,820
-30,252
-2% -$2.19M 0.11% 166
2022
Q2
$130M Buy
1,692,072
+67,035
+4% +$5.11M 0.12% 158
2022
Q1
$119M Buy
1,625,037
+176,074
+12% +$11.8M 0.1% 185
2021
Q4
$90.3M Buy
1,448,963
+167,661
+13% +$9.84M 0.08% 241
2021
Q3
$75.8M Buy
1,281,302
+57,017
+5% +$3.75M 0.07% 255
2021
Q2
$81.8M Buy
1,224,285
+64,427
+6% +$4.2M 0.08% 224
2021
Q1
$73.2M Buy
1,159,858
+52,858
+5% +$3.29M 0.08% 226
2020
Q4
$68.7M Buy
1,107,000
+95,811
+9% +$5.89M 0.09% 213
2020
Q3
$61M Buy
1,011,189
+100,138
+11% +$6.03M 0.1% 197
2020
Q2
$53.6M Buy
911,051
+132,219
+17% +$7.91M 0.09% 198
2020
Q1
$43.4M Buy
778,832
+21,657
+3% +$1.32M 0.09% 188
2019
Q4
$48.6M Buy
757,175
+141,389
+23% +$8.1M 0.09% 198
2019
Q3
$31.2M Sell
615,786
-11,152
-2% -$524K 0.06% 247
2019
Q2
$28.4M Buy
626,938
+37,124
+6% +$1.73M 0.06% 260
2019
Q1
$28.1M Buy
589,814
+62,821
+12% +$3.13M 0.06% 261
2018
Q4
$27.4M Sell
526,993
-1,202
-0.2% -$64.6K 0.07% 231
2018
Q3
$32.8M Sell
528,195
-10,684
-2% -$634K 0.08% 217
2018
Q2
$29.8M Buy
538,879
+11,615
+2% +$627K 0.08% 209
2018
Q1
$33.3M Sell
527,264
-345
-0.1% -$22.2K 0.09% 193
2017
Q4
$32.3M Buy
527,609
+46,114
+10% +$2.88M 0.1% 181
2017
Q3
$30.7M Sell
481,495
-6,658
-1% -$389K 0.11% 170
2017
Q2
$27.2M Buy
488,153
+465,991
+2,103% +$25.4M 0.1% 180
2017
Q1
$1.2M Sell
22,162
-16,099
-42% -$883K 0.01% 1137
2016
Q4
$2.27M Sell
38,261
-52,935
-58% -$2.89M 0.02% 735
2016
Q3
$5.03M Buy
91,196
+24,784
+37% +$1.59M 0.05% 375
2016
Q2
$4.91M Sell
66,412
-561,771
-89% -$39.7M 0.04% 380
2016
Q1
$41.3M Sell
628,183
-61,845
-9% -$3.9M 0.12% 166
2015
Q4
$47.2M Buy
690,028
+289,323
+72% +$19.1M 0.13% 143
2015
Q3
$24.8M Sell
400,705
-8,774
-2% -$557K 0.14% 148
2015
Q2
$27.6M Buy
409,479
+21,788
+6% +$1.44M 0.14% 151
2015
Q1
$24.6M Buy
387,691
+28,900
+8% +$1.81M 0.13% 150
2014
Q4
$21.2M Sell
358,791
-1,166
-0.3% -$65.8K 0.12% 166
2014
Q3
$18.2M Buy
359,957
+16,401
+5% +$819K 0.11% 183
2014
Q2
$16.7M Sell
343,556
-18,641
-5% -$919K 0.1% 189
2014
Q1
$18.8M Sell
362,197
-8,924
-2% -$475K 0.12% 169
2013
Q4
$19.7M Sell
371,121
-56,409
-13% -$2.87M 0.12% 159
2013
Q3
$20.4M Buy
427,530
+16,295
+4% +$715K 0.14% 150
2013
Q2
$18.4M Buy
+411,235
New +$17.9M 0.13% 139

Other funds holding BMY

LPL Financial's BMY Position: Q1 2026 in Review

LPL Financial increased its Bristol-Myers Squibb (BMY) stake by 13% in Q1 2026, buying an estimated $20.9M and bringing the position to 3,212,769 shares worth $195M. The position accounts for 0.05% of the portfolio, ranked #348.

LPL Financial first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $199M in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • LPL Financial held 3,212,769 shares of Bristol-Myers Squibb worth $195M as of Q1 2026.
  • LPL Financial bought 359,262 Bristol-Myers Squibb shares in Q1 2026, an estimated $20.9M.
  • Bristol-Myers Squibb made up 0.05% of LPL Financial's portfolio in Q1 2026, its #348 holding.
  • LPL Financial first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • LPL Financial's Bristol-Myers Squibb position peaked at $199M in Q1 2025.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.